114 related articles for article (PubMed ID: 7319753)
21. Prediction of 5-year survival in advanced-stage ovarian cancer patients based on computed tomography peritoneal carcinomatosis index.
Diaz-Gil D; Fintelmann FJ; Molaei S; Elmi A; Hedgire SS; Harisinghani MG
Abdom Radiol (NY); 2016 Nov; 41(11):2196-2202. PubMed ID: 27338731
[TBL] [Abstract][Full Text] [Related]
22. [Preoperative staging of patients with primary ovarian carcinoma by CT and MRI].
Zhu Q; Yoshikawa H; Fujita N
Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):296-9. PubMed ID: 11776821
[TBL] [Abstract][Full Text] [Related]
23. PET-CT detection of abdominal recurrence of ovarian cancer: radiologic-surgical correlation.
Pannu HK; Cohade C; Bristow RE; Fishman EK; Wahl RL
Abdom Imaging; 2004; 29(3):398-403. PubMed ID: 15354347
[TBL] [Abstract][Full Text] [Related]
24. Value of chest CT scans in routine ovarian carcinoma follow-up.
Sella T; Rosenbaum E; Edelmann DZ; Agid R; Bloom AI; Libson E
AJR Am J Roentgenol; 2001 Oct; 177(4):857-9. PubMed ID: 11566689
[TBL] [Abstract][Full Text] [Related]
25. Correlation of computed tomography with second-look laparotomy in ovarian carcinoma.
Sandhu M; Kumar L; Kumar S; Kriplani A; Bhatla N; Kinra G
Natl Med J India; 1996; 9(1):13-6. PubMed ID: 8713518
[TBL] [Abstract][Full Text] [Related]
26. Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy.
Rose PG; Faulhaber P; Miraldi F; Abdul-Karim FW
Gynecol Oncol; 2001 Jul; 82(1):17-21. PubMed ID: 11426956
[TBL] [Abstract][Full Text] [Related]
27. Role of video-assisted thoracoscopy in patients with ovarian cancer and pleural effusion.
Cohen-Mouly S; Badia A; Bats AS; Barthes F; Bensaïd C; Riquet M; Lécuru F
Int J Gynecol Cancer; 2009 Dec; 19(9):1662-5. PubMed ID: 19955956
[TBL] [Abstract][Full Text] [Related]
28. CT of epithelial ovarian tumors.
Kawamoto S; Urban BA; Fishman EK
Radiographics; 1999 Oct; 19 Spec No():S85-102; quiz S263-4. PubMed ID: 10517447
[TBL] [Abstract][Full Text] [Related]
29. A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer.
Hynninen J; Kemppainen J; Lavonius M; Virtanen J; Matomäki J; Oksa S; Carpén O; Grénman S; Seppänen M; Auranen A
Gynecol Oncol; 2013 Nov; 131(2):389-94. PubMed ID: 23994535
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic performance of 18F-FDG PET/contrast-enhanced CT versus contrast-enhanced CT alone for post-treatment detection of ovarian malignancy.
Tawakol A; Abdelhafez YG; Osama A; Hamada E; El Refaei S
Nucl Med Commun; 2016 May; 37(5):453-60. PubMed ID: 26745811
[TBL] [Abstract][Full Text] [Related]
31. Computed tomography prior to second-look operation in advanced ovarian cancer.
Goldhirsch A; Triller JK; Greiner R; Dreher E; Davis BW
Obstet Gynecol; 1983 Nov; 62(5):630-4. PubMed ID: 6621953
[TBL] [Abstract][Full Text] [Related]
32. [Predictive value of preoperative abdominopelvic CT for optimal cytoreduction surgery in ovarian carcinoma].
Taïeb S; Bonodeau F; Leblanc é ; Vennin P; Fournier C; Besson P
Bull Cancer; 2000 Mar; 87(3):265-72. PubMed ID: 10779815
[TBL] [Abstract][Full Text] [Related]
33. A comparison of findings at second-look laparotomy with preoperative computed tomography in patients with ovarian cancer.
Stehman FB; Calkins AR; Wass JL; Smirz LR; Sutton GP; Ehrlich CE
Gynecol Oncol; 1988 Jan; 29(1):37-42. PubMed ID: 3338662
[TBL] [Abstract][Full Text] [Related]
34. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
Lopez-Lopez V; Cascales-Campos PA; Gil J; Frutos L; Andrade RJ; Fuster-Quiñonero M; Feliciangeli E; Gil E; Parrilla P
Eur J Radiol; 2016 Oct; 85(10):1824-1828. PubMed ID: 27666623
[TBL] [Abstract][Full Text] [Related]
35. Computerized tomography of the abdomen and pelvis with peritoneal administration of soluble contrast (IPC-CT) in detection of residual disease for patients with ovarian cancer.
Frasci G; Contino A; Iaffaioli RV; Mastrantonio P; Conforti S; Persico G
Gynecol Oncol; 1994 Feb; 52(2):154-60. PubMed ID: 8314132
[TBL] [Abstract][Full Text] [Related]
36. From the archives of the AFIP: radiologic staging of ovarian carcinoma with pathologic correlation.
Woodward PJ; Hosseinzadeh K; Saenger JS
Radiographics; 2004; 24(1):225-46. PubMed ID: 14730048
[TBL] [Abstract][Full Text] [Related]
37. 18F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer.
Vallius T; Peter A; Auranen A; Carpén O; Kemppainen J; Matomäki J; Oksa S; Roering P; Seppänen M; Grénman S; Hynninen J
Gynecol Oncol; 2016 Jan; 140(1):29-35. PubMed ID: 26515076
[TBL] [Abstract][Full Text] [Related]
38. FDG-PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary results.
Alessi A; Martinelli F; Padovano B; Serafini G; Lorusso D; Lorenzoni A; Ditto A; Lecce F; Mira M; Donfrancesco C; Raspagliesi F; Crippa F
Tumori; 2016; 102(1):103-7. PubMed ID: 26350201
[TBL] [Abstract][Full Text] [Related]
39. The use of CT findings to predict extent of tumor at primary surgery for ovarian cancer.
Glaser G; Torres M; Kim B; Aletti G; Weaver A; Mariani A; Hartmann L; Cliby W
Gynecol Oncol; 2013 Aug; 130(2):280-3. PubMed ID: 23672930
[TBL] [Abstract][Full Text] [Related]
40. Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment.
Picchio M; Sironi S; Messa C; Mangili G; Landoni C; Gianolli L; Zangheri B; Viganò R; Aletti G; De Marzi P; De Cobelli F; Del Maschio A; Ferrari A; Fazio F
Q J Nucl Med; 2003 Jun; 47(2):77-84. PubMed ID: 12865867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
